Medicine Description galvus 50 mg
galvus 50 mg tablets is a medication that contains vildagliptin, a DPP-4 inhibitor. It functions by inhibiting the dipeptidyl peptidase-4 enzyme, which is responsible for the degradation of incretin hormones. These hormones, such as GLP-1 and GIP, play a critical role in glucose metabolism. By prolonging the action of incretins, galvus enhances insulin secretion from the pancreas in response to elevated blood glucose levels and reduces the hepatic glucose production. This dual mechanism contributes to improved glycemic control in individuals with type 2 diabetes.
Indications and Uses of galvus 50 mg tablets
- Management of type 2 diabetes mellitus in adults.
- Usage as monotherapy or in combination with other oral antidiabetic agents.
- Support in achieving targeted blood sugar levels when diet and exercise are insufficient.
Side Effects of galvus 50 mg tablets
- Headache
- Nausea
- Dizziness
- Hypoglycemia when used with other antidiabetic medications
- Pancreatitis
- Allergic reactions
Storage and Handling
Store galvus 50 mg tablets in a cool, dry place at room temperature, away from direct sunlight and moisture. Keep out of reach of children.
Patient Advice and Precautions
Regular monitoring of blood glucose levels is essential to assess the effectiveness of the treatment. Maintain a balanced diet and engage in physical activity as advised by your healthcare provider. Be aware of signs of low blood sugar and have a source of fast-acting sugar available. Report any unusual symptoms, such as persistent abdominal pain, to your healthcare professional promptly.